Literature DB >> 15151169

Effect of erythrocytes on the hepatic distribution kinetics of antipyrine.

Selma Sahin1, Malcolm Rowland.   

Abstract

The role of erythrocyte on the hepatic distribution kinetics of antipyrine was investigated in the in situ isolated perfused rat liver. Perfusion experiments were conducted using Krebs-bicarbonate buffer delivered via the portal vein in a single pass mode at a total flow rate of 15 ml/min. A bolus dose of antipyrine was administered in the presence and absence of erythrocytes. Almost identical moment analysis results (without erythrocytes mean transit time, MTT: 23 s; volume of distribution, VH: 0.57 ml/g liver and with erythrocytes, MTT: 24 s; VH: 0.60 ml/g liver) and superimposable unimodal effluent curves were obtained in the presence and absence of erythrocytes indicates that distribution kinetics of antipyrine within the liver is not affected by erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151169     DOI: 10.1007/BF03190572

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  25 in total

1.  Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process.

Authors:  D Y Hung; P Chang; M Weiss; M S Roberts
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

2.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

3.  The use of antipyrine in the measurement of total body water in man.

Authors:  R SOBERMAN; B B BRODIE
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

4.  Effect of erythrocyte binding on elimination of harmol by the isolated perfused rat liver.

Authors:  D J Morgan; A Guttmann; R G Watson; H Ghabrial; S L Elliott; R A Smallwood
Journal:  J Pharm Sci       Date:  1996-01       Impact factor: 3.534

5.  Endothelial and epithelial permeabilities to antipyrine in rat and dog lungs.

Authors:  W O Cua; G Basset; F Bouchonnet; R A Garrick; G Saumon; F P Chinard
Journal:  Am J Physiol       Date:  1990-05

6.  Uptake of lactate by the liver: effect of red blood cell carriage.

Authors:  C A Goresky; G G Bach; A Simard; A J Schwab; A Bracht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-05       Impact factor: 4.052

7.  Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.

Authors:  K S Pang; F Barker; A J Schwab; C A Goresky
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

8.  Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

9.  Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.

Authors:  W Piekoszewski; F S Chow; W J Jusko
Journal:  Drug Metab Dispos       Date:  1993 Jul-Aug       Impact factor: 3.922

10.  Sulfation of acetaminophen by the perfused rat liver: the effect of red blood cell carriage.

Authors:  K S Pang; F Barker; A Simard; A J Schwab; C A Goresky
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

View more
  1 in total

1.  Estimation of hepatic distributional volumes using non-labeled reference markers.

Authors:  Yasemin Karabey; Selma Sahin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.